NIH Common Fund Data Ecosystem (CFDE) FAIR Rubric

A rubric for evaluating the FAIRness of NIH-CFDE Resources

Tags: nihcommonfund

URL(s):

View Associations

Rubric Assessments (626384)


Assessment Metrics Date
Target Project   Contact information is provided for the creator(s) of the dataset. Globally unique identifier Machine-readable metadata Standardized metadata Resource identifier in metadata Open, Free, Standardized Access protocol Digital resource license Metadata license NIH program name is available for querying NIH project name is available for querying The institution that created this dataset is available A biological assay is present and resolvable in CFDE-specified ontology (OBI) A relevant anatomical part is present and resolvable in the UBERON Ontology A relevant disease is present and resolvable in the MONDO Ontology A relevant file type is present and resolvable in the EDAM Ontology A relevant taxonomy is present and resolvable in the NCBITaxon Ontology A relevant cell line is present and resolvable in the Cellosaurus Ontology A landing page exists and is accessible
Define alterations in the gut metabolome of mice infected with C. difficile Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
2 lines of pulmonary artery smooth muscle cells metabolic profile (122 vs 3633C central metabolic profile) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Yeast glycolysis in normoxia and hypoxia (150121_pkf2) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Sulfonates in marine plankton Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Global LC-MS of Ozone Stress in Maize: GLCMS Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Disruption of Zinc homeostasis can impair maternal glucocorticoid metabolism: consequences on the developing fetus Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Metabolomics of uterine fluid of the cow Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Tibetan medicine Shi-Wei-Gan-Ning-Pill (SWGNP) protect rats from ccl4 induced liver fibrosis.(Part I: Liver) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Bile acid targeted metabolomics of the small intestine in malnourished and control mice Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Metabolic Adaptations to Chronic and Acute Exercise in Overweight Adults (ATX-Study) preliminary data Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Untargeted metabolomics and lipidomics of scleroderma PAH discovery cohort Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Tibetan medicine Shi-Wei-Gan-Ning-Pill (SWGNP) protect rats from ccl4 induced liver fibrosis (Part II: Serum) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Metabolomics of Shark Bay stromatolites Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Omega-6 and omega-3 oxylipins are implicated in soybean oil-induced obesity in mice (part III) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Timecourse of TCA isotopomers in LNCaP Cells Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Metabolomics analysis of colon adenoma in African Americans Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
FASN effect on HCT116 metabolism probed by 13C6-glucose tracer (part II) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Metabolic change in macrophages after efferocytosis (part II) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Metabolomics of diabetic nephropathy Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-I) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Amino Acid Metabolites of Dietary Salt Effects on Blood Pressure in Rat Urine and Kidney Tissue (part XI) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
WT and ?SPT cultures of B. thetaiotaomicron grown in Minimal Media (part II) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Insights into myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) phenotypes through comprehensive metabolomics Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Metabolite changes associated with methionine stress sensitivity of cancer (GC TOF MS analysis) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Metabolomics of mice inoculated with human microbiota Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019